Notice - Revision to Guidance Document: Submission of Pharmacogenomic Information
Information
Type
Guidance
Regulated products
Medical Devices
Topics
Medical Devices Guidance Documents, Health And Safety
Published
March 7, 2006
Last updated
August 13, 2008
Description
Provides guidance on how and when to submit pharmacogenomic information to Health Canada, in support of an application or submission for a drug, biologic drug, or medical device intended for human use, or as part of ongoing post-market activities
Tags
Organization
Country / Region
Canada
License
Open Government License 2.0 (Canada)